Clinical trial
Modification of Doses of Efavirenz According to Its Blood Concentration in HIV…
NCT00299091 · Germans Trias i Pujol Hospital, Other · Completed
Key facts
| NCT number | NCT00299091 |
|---|---|
| Title | Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients |
| Official title | Open, Parallel and Randomised Pilot Clinical Trial to Evaluate the Utility of the Therapeutic Monitoring of Plasma Levels of Efavirenz in Hiv-Infected Patients Initiating an Antiretroviral Treatment Regimen With Sustiva |
| Lead sponsor | Germans Trias i Pujol Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | Efavirenz capsules 200 mg and 600 mg |
| Enrollment | 31 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 6, 2006 |
| Last update posted | Feb 14, 2018 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: